...
首页> 外文期刊>Advances in Pharmaceutics >Nanoemulsion Based Hydrogel for Enhanced Transdermal Delivery of Ketoprofen
【24h】

Nanoemulsion Based Hydrogel for Enhanced Transdermal Delivery of Ketoprofen

机译:基于纳米乳液的水凝胶可增强酮洛芬的透皮递送

获取原文
           

摘要

The aim of the present study was to investigate the nanoemulgel as transdermal delivery system for poorly water soluble drug, ketoprofen, in order to overcome the troubles associated with its oral delivery. Different nanoemulsion components (oil, surfactant, and cosurfactant) were selected on the basis of solubility and emulsification ability. Pseudoternary phase diagrams were constructed using titration method to figure out the concentration range of components. Carbomer 940 was added as gel matrix to convert nanoemulsion into nanoemulgel. Drug loaded nanoemulsions and nanoemulgels were characterized for particle size, TEM, viscosity, conductivity, spreadability, rheological behavior, and permeation studies using Wistar rat skin and stability studies. Transdermal permeation of ketoprofen from nanoemulgels was determined by using Franz diffusion cell. Nanoemulgel containing 6% oleic acid as oil, 35% Tween 80, and Transcutol P as surfactant cosurfactant mixture, 56.5% water, 2.5% drug, and 0.6% carbomer was concluded as optimized formulation (NG6). Theex vivopermeation profile of optimized formulation was compared with nanoemulsion and marketed formulation (Fastum). Nanoemulgel showed significantly higher (P<0.05) cumulative amount of drug permeated and flux along with lower lag time and skin retention than marketed formulation. Thus, the study substantiated that nanoemulgel formulation can be used as a feasible alternative to conventional formulations of ketoprofen with advanced permeation characteristics for transdermal application.
机译:本研究的目的是研究纳米乳胶作为水溶性差的药物酮洛芬的透皮给药系统,以克服与其口服给药相关的麻烦。基于溶解度和乳化能力选择不同的纳米乳液组分(油,表面活性剂和助表面活性剂)。用滴定法建立了伪三元相图,以求出各组分的浓度范围。加入卡波姆940作为凝胶基质,以将纳米乳液转化为纳米乳液。使用Wistar大鼠皮肤和稳定性研究对载药的纳米乳剂和纳米乳剂的粒径,TEM,粘度,电导率,可延展性,流变行为和渗透性进行了表征。通过使用Franz扩散池测定酮洛芬从纳米乳剂的透皮渗透。得出的纳米乳胶为优化配方(NG6),该纳米乳胶包含6%的油酸(油),35%的Tween 80和Transcutol P(作为表面活性剂辅助表面活性剂混合物),56.5%的水,2.5%的药物和0.6%的卡波姆。将优化制剂的体内渗透曲线与纳米乳液和市售制剂(Fastum)进行比较。与市售配方相比,纳米乳胶的药物渗透和通量累积量显着更高(P <0.05),滞后时间和皮肤滞留时间更低。因此,该研究证实了纳米乳胶制剂可以用作酮洛芬常规制剂的可行替代品,该酮洛芬具有先进的渗透特性,可用于透皮应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号